GlassScriptPhysician profile
Megan E Fitzgerald
NPI 1750830758
$5,374.60
in general payments reported to CMS, 2019-2025
20 companies · $1,169 in 2025
The $1,169 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $888 · 2022: $946 · 2023: $1,088 · 2024: $1,283 · 2025: $1,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,540.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,377.94 | 2021-2025 | |
| Lilly USA, LLC | $696.76 | 2021-2024 | Taltz, Olumiant |
| Incyte Corporation | $366.93 | 2022-2024 | Opzelura |
| Arcutis Biotherapeutics, INC. | $366.93 | 2024-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $330.25 | 2021-2025 | Cabtreo |
| Ucb, INC. | $330.17 | 2022-2025 | Bimzelx |
| Revance Therapeutics, INC. | $292.49 | 2024 | Daxxify |
| E.R. Squibb & Sons, L.L.C. | $177.56 | 2021-2023 | |
| Botanix Sb INC | $140.90 | 2025 | Sofdra |
| Depuy Synthes Sales INC. | $133.22 | 2024 | Monovisc, Orthovisc |
| Leo Pharma INC. | $122.69 | 2025 | Anzupgo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.31 | 2023 | Spevigo |
| Genzyme Corporation | $122.31 | 2025 | |
| Galderma Laboratories, L.P. | $122.31 | 2025 | Nemluvio |
| Dermavant Sciences, INC. | $122.31 | 2023 | Vtama |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $117.33 | 2021 | |
| Pfizer INC. | $116.20 | 2023 | |
| Sun Pharmaceutical Industries INC. | $109.39 | 2022 | |
| Janssen Scientific Affairs, LLC | $106.60 | 2022 | |
| Sanofi-Aventis U.S. LLC | $100.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Fitzgerald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.